Glycine and Prograf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glycine (glycine) and Prograf (tacrolimus). Common drug interactions include amniotic cavity infection among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Glycine and Prograf. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Glycine?

Glycine has active ingredients of glycine. eHealthMe is studying from 1,063 Glycine users. Check the latest studies of Glycine.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.

On Jul, 12, 2026

15 people who take Glycine and Prograf together, and have interactions are studied.

What are the common drug interactions of Glycine and Prograf, by gender? *:

female:

Amniotic cavity infection
Chronic graft versus host disease (immune cells attack the host's body cells after transplant)
Hypokalaemia (low potassium)
Maternal exposure during pregnancy (use of substance during pregnancy)
Premature delivery
Platelet count decreased
Renal impairment (severely reduced kidney function)
Thrombocytopenia (decrease of platelets in blood)
Alopecia (absence of hair from areas of the body)
Appendicitis (inflammation of the appendix)

male:

Pyrexia (fever)
Pneumonia
Lymphadenopathy (disease or enlargement of lymph nodes)
Platelet count decreased
White blood cell count decreased
Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Hypertension (high blood pressure)
Klebsiella sepsis (klebsiella causes a potentially fatal whole-body inflammation)
Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Glycine and Prograf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Pyrexia (fever)
Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Hypertension (high blood pressure)
Klebsiella sepsis (klebsiella causes a potentially fatal whole-body inflammation)
Nausea (feeling of having an urge to vomit)
Stomatitis (inflammation of mucous membrane of mouth)

20-29:

n/a

30-39:

Premature delivery
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Blood creatine phosphokinase increased
Gamma-glutamyltransferase increased
General physical health deterioration (weak health status)
Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
Hepatic vein occlusion (blockage of the hepatic vein)
Lymphadenopathy (disease or enlargement of lymph nodes)

40-49:

Chronic graft versus host disease (immune cells attack the host's body cells after transplant)
Hypokalaemia (low potassium)
Platelet count decreased
Femur fracture
Pneumonia
Prinzmetal angina (cardiac chest pain at rest that occurs in cycles)

50-59:

Appendicitis (inflammation of the appendix)
Bacterial infection

60+:

n/a

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 40.00%
Hepatic Function Abnormal: 6 people, 40.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 26.67%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 4 people, 26.67%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 3 people, 20.00%
Iron Deficiency Anaemia: 2 people, 13.33%
Alanine Aminotransferase Increased: 2 people, 13.33%
Aspartate Aminotransferase Increased: 2 people, 13.33%
Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 2 people, 13.33%
Immunodeficiency Disorders: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Glycine and Prograf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously